Tavneos Withdrawal Exposes What BIMO Can't See
CDER's proposed withdrawal of avacopan rests on post-unblinding readjudication that no inspection caught — and lands in the same week as new BIMO guidance, ISO 14155:2026, and a peer-reviewed audit of QTL methods.